Differential Prognostic Value of Residual Nodal Burden in Breast Cancer Subtypes

被引:0
|
作者
An, Selena J. [1 ]
Che, Christine Hong Ngoc [1 ]
Haase, Conner [1 ]
Selfridge, Julia M. [1 ]
Agala, Chris [2 ]
Gallagher, Kristalyn K. [3 ]
Spanheimer, Philip [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC USA
[2] UNC Hosp, Chapel Hill, NC USA
[3] UNC, Sch Med, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E2
引用
收藏
页码:S83 / S83
页数:1
相关论文
共 50 条
  • [21] Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?
    Tiffanie Jones
    Hanmanth Neboori
    H. Wu
    Qifeng Yang
    Bruce G. Haffty
    Susan Evans
    Susan Higgins
    Meena S. Moran
    Annals of Surgical Oncology, 2013, 20 : 2866 - 2872
  • [22] Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy
    Peintinger, Florentia
    Sinn, Bruno
    Hatzis, Christos
    Albarracin, Constance
    Downs-Kelly, Erinn
    Morkowski, Jerzy
    Gould, Rebekah
    Symmans, W. Fraser
    MODERN PATHOLOGY, 2015, 28 (07) : 913 - 920
  • [23] Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy
    Hamy, Anne-Sophie
    Darrigues, Lauren
    Laas, Enora
    De Croze, Diane
    Topciu, Lucian
    Lam, Giang-Thanh
    Evrevin, Clemence
    Rozette, Sonia
    Laot, Lucie
    Lerebours, Florence
    Pierga, Jean-Yves
    Osdoit, Marie
    Faron, Matthieu
    Feron, Jean-Guillaume
    Lae, Marick
    Reyal, Fabien
    PLOS ONE, 2020, 15 (06):
  • [24] Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer
    Kainz, C
    Lösch, A
    Tempfer, CC
    Hefter, L
    Kucera, EE
    Sliutz, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S20 - S21
  • [25] Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer
    A Lösch
    C Tempfer
    P Kohlberger
    EA Joura
    M Denk
    B Zajic
    G Breitenecker
    C Kainz
    British Journal of Cancer, 1998, 78 : 205 - 209
  • [26] Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer
    Lösch, A
    Tempfer, C
    Kohlberger, P
    Joura, EA
    Denk, M
    Zajic, B
    Breitenecker, G
    Kainz, C
    BRITISH JOURNAL OF CANCER, 1998, 78 (02) : 205 - 209
  • [27] Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
    Hannah Deborah Müller
    Florian Posch
    Christoph Suppan
    Ute Bargfrieder
    Melanie Gumpoldsberger
    Robert Hammer
    Hubert Hauser
    Nadia Dandachi
    Kurt Prein
    Herbert Stoeger
    Sigurd Lax
    Marija Balic
    Annals of Surgical Oncology, 2019, 26 : 4274 - 4283
  • [28] A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer
    Mukhtar, Rita A.
    Gottipati, Soumya
    Yau, Christina
    Lopez-Tarruella, Sara
    Earl, Helena
    Hayward, Larry
    Hiller, Louise
    Osdoit, Marie
    van der Noordaa, Marieke
    de Croze, Diane
    Hamy, Anne-Sophie
    Lae, Marick
    Reyal, Fabien
    Sonke, Gabe S.
    Steenbruggen, Tessa G.
    van Seijen, Maartje
    Wesseling, Jelle
    Martin, Miguel
    del Monte-Millan, Maria
    Boughey, Judy C.
    Goetz, Matthew P.
    Hoskin, Tanya
    Valero, Vicente
    Edge, Stephen B.
    Abraham, Jean E.
    Bartlett, John M. S.
    Caldas, Carlos
    Dunn, Janet
    Provenzano, Elena
    Sammut, Stephen-John
    Thomas, Jeremy S.
    Graham, Ashley
    Hall, Peter
    Mackintosh, Lorna
    Fan, Fang
    Godwin, Andrew K.
    Schwensen, Kelsey
    Sharma, Priyanka
    Demichele, Angela M.
    Cole, Kimberly
    Pusztai, Lajos
    Kim, Mi-Ok
    van 't Veer, Laura
    Cameron, David
    Esserman, Laura J.
    Fraser Symmans, W.
    NPJ BREAST CANCER, 2025, 11 (01)
  • [29] The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
    Xu, Xin
    Zhao, Wei
    Liu, Cuicui
    Gao, Yongsheng
    Chen, Dawei
    Wu, Meng
    Li, Chao
    Wang, Xinzhao
    Song, Xiang
    Yu, Jinming
    Liu, Zhaoyun
    Yu, Zhiyong
    BMC CANCER, 2024, 24 (01)
  • [30] Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
    Mueller, Hannah Deborah
    Posch, Florian
    Suppan, Christoph
    Bargfrieder, Ute
    Gumpoldsberger, Melanie
    Hammer, Robert
    Hauser, Hubert
    Dandachi, Nadia
    Prein, Kurt
    Stoeger, Herbert
    Lax, Sigurd
    Balic, Marija
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (13) : 4274 - 4283